InterMune (ITMN) shares +9.8% premarket after the company said late yesterday it's selling the...

|By:, SA News Editor

InterMune (ITMN) shares +9.8% premarket after the company said late yesterday it's selling the rights to its experimental Hepatitis C drug danoprevir to Roche (RHHBY.PK) for $175M. (PR)